Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
Publication
, Journal Article
Doolittle, ND; Abrey, LE; Ferrari, N; Hall, WA; Laws, ER; McLendon, RE; Muldoon, LL; Peereboom, D; Peterson, DR; Reynolds, CP; Senter, P; Neuwelt, EA
Published in: Clin Cancer Res
June 2002
The November 2000 NIH report of the Brain Tumor Progress Review Group identified delivering and targeting therapeutic agents as a priority in the treatment of malignant brain tumors. For this reason, the seventh annual Blood-Brain Barrier Disruption Consortium meeting, partially funded by an NIH R13 Grant, focused on recent advances in targeted delivery to the central nervous system, clinical trials for primary and metastatic brain tumors using enhanced chemotherapy delivery, and strategies to lessen the toxicities associated with dose intensive treatments, using thiols.
Duke Scholars
Published In
Clin Cancer Res
ISSN
1078-0432
Publication Date
June 2002
Volume
8
Issue
6
Start / End Page
1702 / 1709
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Drug Implants
- Drug Delivery Systems
- Combined Modality Therapy
- Clinical Trials as Topic
- Brain Neoplasms
- Blood-Brain Barrier
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Doolittle, N. D., Abrey, L. E., Ferrari, N., Hall, W. A., Laws, E. R., McLendon, R. E., … Neuwelt, E. A. (2002). Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium. Clin Cancer Res, 8(6), 1702–1709.
Doolittle, Nancy D., Lauren E. Abrey, Nicolay Ferrari, Walter A. Hall, Edward R. Laws, Roger E. McLendon, Leslie L. Muldoon, et al. “Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.” Clin Cancer Res 8, no. 6 (June 2002): 1702–9.
Doolittle ND, Abrey LE, Ferrari N, Hall WA, Laws ER, McLendon RE, et al. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium. Clin Cancer Res. 2002 Jun;8(6):1702–9.
Doolittle, Nancy D., et al. “Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.” Clin Cancer Res, vol. 8, no. 6, June 2002, pp. 1702–09.
Doolittle ND, Abrey LE, Ferrari N, Hall WA, Laws ER, McLendon RE, Muldoon LL, Peereboom D, Peterson DR, Reynolds CP, Senter P, Neuwelt EA. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium. Clin Cancer Res. 2002 Jun;8(6):1702–1709.
Published In
Clin Cancer Res
ISSN
1078-0432
Publication Date
June 2002
Volume
8
Issue
6
Start / End Page
1702 / 1709
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Humans
- Drug Implants
- Drug Delivery Systems
- Combined Modality Therapy
- Clinical Trials as Topic
- Brain Neoplasms
- Blood-Brain Barrier
- Antineoplastic Agents
- 3211 Oncology and carcinogenesis